最新国产福利在线观看精品_99视频只有精品_日韩亚洲亚洲综合_免费黄色一级毛片_美女黄裸身无遮挡免费观看的网站_国产精品久久孕妇大杂乱_91看片淫黃大片_欧美一区4卡黑人_欧美成人国产高清视频_三级在线的特黄视频网站

收縮
PRODUCTS
PRODUCTS
Your current location:Home > Our Products >> Bone Biomarkers
COMP® ELISA

COMP® ELISA

 

Product Description

The COMP® ELISA is a quantitative enzyme-linked immunosorbent assay for the determination of Cartilage Oligomeric Matrix Protein (COMP) in human serum.

The presence of elevated levels, when considered in conjunction with other laboratory and clinical findings, is an aid in identifying aggressive destruction of joint tissue in diseases such as rheumatoid arthritis (RA).

 

Scientific Description

It is well documented that when articular cartilage matrix is degraded by a disease process, protein fragments are produced and diffuse out into the joint fluid. Some of these proteins, such as COMP, subsequently appear in the bloodstream and can be used to monitor the progress of cartilage degradation in inflammatory joint diseases such as rheumatoid arthritis1, 2 and osteoarthritis3.

A quantitative relation has been shown between the concentrations of COMP in serum and cartilage degradation using radiographic changes as a surrogate clinical endpoint.

 

Key Features and Values

The following guidelines may be used to assess ongoing cartilage turnover and the risk of joint destruction in the future:

·        < 12 U/L Lower risk of aggressive joint destruction

·        12-15 U/L Increasing risk of aggressive joint destruction

·        > 15 U/L High risk of aggressive joint destruction

Kit Info

Code:

AN-14-1006-71

Certification:

CE Marked

Clinical Area:

Cartilage Markers

Type:

Manual

Format:

ELISA

RUO/IVD:

IVD

Number of Tests:

96 (40 samples in duplicate)

Sample Type:

Serum, Heparin Plasma

Sample Volume:

25 μL (pre-diluted 1/10)

Assay Range:

N/A

 

Publications

Dénarié D et al., Could biomarkers of bone, cartilage or synovium turnover be used for relapse prediction in rheumatoid arthritis patients? Mediators Inflamm. 2014;2014:537324.

Turesson C et al., Increased cartilage turnover and circulating auto-antibodies in different subsets before the clinical onset of rheumatoid arthritis. Ann Rheum Dis. 2011;70:520-522.

Sowers MF et al., Longitudinal changes of serum COMP and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women.

Complementary Products

Bone Markers
Urine CartiLaps ELISA

 

HomeAbout usNews CentreProducts CentreRecruitmentContact us
© Copyright Beijing Rongzhi Haida Biotech Co., Ltd.
Beijing headquarters Tel:+86.10.5889.5809 +86.10.5889.5646 Fax: +86.10.5889.5611 E-mail:market@rz-biotech.com
(BJ)ICP12047214 Technical support:wanmeiweb.com